Completed PHASE2 INTERVENTIONAL 1-arm NCT03321929

Intraoperative Detection of Residual Cancer in Breast Cancer

Feasibility Study Phase C: Expansion Into Multiple Institutions for Training in the Use of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer

Sponsor: Lumicell, Inc.

Conditions Breast Cancer

Interventions LUM Imaging System

Updated 21 times since 2017 Last updated: Apr 6, 2023 Started: Feb 6, 2018 Primary completion: Apr 10, 2020 Completion: Apr 10, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03321929, this PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by Lumicell, Inc., it has been updated 21 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

21 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jun 2023 — Jul 2024 [monthly]

Completed PHASE2
Apr 2022 — Jun 2023 [monthly]

Completed PHASE2
May 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 16 earlier versions

Mar 2021 — May 2021 [monthly]

Completed PHASE2
Jan 2021 — Mar 2021 [monthly]

Completed PHASE2
Aug 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Mar 2020 — Aug 2020 [monthly]

Active Not Recruiting PHASE2
Feb 2020 — Mar 2020 [monthly]

Active Not Recruiting PHASE2
Nov 2019 — Feb 2020 [monthly]

Active Not Recruiting PHASE2
Sep 2019 — Nov 2019 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Jun 2019 — Sep 2019 [monthly]

Recruiting PHASE2

Phase: NA → PHASE2
Mar 2019 — Jun 2019 [monthly]

Recruiting NA
Feb 2019 — Mar 2019 [monthly]

Recruiting NA
Oct 2018 — Feb 2019 [monthly]

Recruiting NA
Sep 2018 — Oct 2018 [monthly]

Recruiting NA
Jun 2018 — Sep 2018 [monthly]

Recruiting NA
Jan 2018 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2017 — Jan 2018 [monthly]

Not Yet Recruiting NA

Status: Withheld → Not Yet Recruiting
Nov 2017 — Dec 2017 [monthly]

Withheld NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lumicell, Inc.
National Cancer Institute (NCI)

Data source: Lumicell, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boston, United States , Burlington, United States , Clearwater, United States , Cleveland, United States , Dallas, United States , Durham, United States , Hershey, United States , Houston, United States , Jacksonville, United States , Mobile, United States and 6 more locations